Notification That Form 20-f Will Be Submitted Late (nt 20-f)
May 02 2022 - 5:26PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
One): |
☐ Form
10-K ☒ Form 20-F ☐ Form
11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form
N-SAR ☐ Form N-CSR |
|
|
|
|
For
Period Ended: |
DECEMBER
31, 2021 |
|
|
|
☐ Transition
Report on Form 10-K |
|
☐ Transition
Report on Form 20-F |
|
☐ Transition
Report on Form 11-K |
|
☐ Transition
Report on Form 10-Q |
|
☐ Transition
Report on Form N-SAR |
|
|
|
|
For
the Transition Period Ended: ________________________ |
Read
Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission
has
verified any information contained herein. |
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I -- REGISTRANT INFORMATION
Molecular
Data Inc.
Full
Name of Registrant
|
Former Name
if Applicable |
5/F,BUILDING
12,1001 NORTH QINZHOU ROAD,
Address
of Principal Executive Office (Street and Number)
XUHUI
DISTRICT, SHANGHAI, CHINA, 201109
City,
State and Zip Code
PART
II -- RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b),
the following should be completed. (Check box if appropriate)
☒ |
(a) |
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense |
|
(b) |
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the
fifth calendar day following the prescribed due date; and |
|
(c) |
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART
III -- NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not
be filed within the prescribed time period. (Attach extra Sheets if Needed)
The
Registrant was unable, without unreasonable effort or expense, to file its Annual Report on Form 20-F for the period ended December 31,
2021 (the “Annual Report”) by the May 2, 2022 filing date due to a delay experienced by the Registrant in finalizing its
financial statements and other disclosures in the Annual Report. Much of the Registrant’s operations are located in Shanghai, which
has been affected by government lockdowns related to the coronavirus pandemic.
PART
IV -- OTHER INFORMATION
(1) |
Name and telephone
number of person to contact in regard to this notification |
Steven
Foo |
|
(8621) |
|
54365166 |
(Name) |
|
(Area
Code) |
|
(Telephone
Number) |
(2) |
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If answer is no, identify report(s). |
|
☒ Yes ☐ No |
(3) |
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof ? |
|
☐ Yes ☒ No |
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
Molecular
Data Inc. |
(Name
of Registrant as Specified in Charter) |
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date |
May
2, 2022 |
|
By |
/s/
Steven Foo |
|
|
|
|
Steven Foo,
Chief Executive Officer and Chief Financial Officer |
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Molecular Data (NASDAQ:MKD)
Historical Stock Chart
From Sep 2023 to Sep 2024